http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014132919-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716e9a2606ffd4ba1a2a3917e4a402fd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0455 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
| filingDate | 2014-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac5222cc97945306bf8cee653451dfde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_144aa38d11729f8b020889dbbd2ca279 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e3f3699093c01bc842590a8dd2fcdc2 |
| publicationDate | 2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014132919-A1 |
| titleOfInvention | Diagnostic composition |
| abstract | The purpose of the present invention is to provide a β-amyloid protein imaging probe for SPECT that is clinically usable in practice and an imaging probe for diagnosing diabetes. Provided is a composition for diagnosing a conformation disease, characterized by comprising a compound represented by general formula (I) [wherein: one of R 1 , R 2 , R 3 and R 4 represents a radioactive iodine atom and the remainder represent a hydrogen atom; R 5 , R 6 , R 7 and R 8 independently represent a hydrogen atom, an amino group, a methylamino group, a dimethylamino group, a methoxy group or a hydroxy group; and X represents CH or N] or a pharmaceutically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106631908-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106631908-B |
| priorityDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.